Four major clinical trial networks based in low resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative (“GCTC”) to enhance clinical research in low resource settings. By promoting the unique qualities of randomized controlled trials (RCTs) and the evidence they produce, the collaboration aims to support regional research ecosystems to prioritize collaborative, informative and efficient research responses to public health challenges.
Four major clinical trial networks based in low resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative to enhance clinical research in low resource settings.
In patients hospitalised for COVID-19 with clinical hypoxia who required either no
oxygen or simple oxygen only, higher dose corticosteroids significantly increased
the risk of death compared with usual care, which included low-dose corticosteroids.
The RECOVERY trial continues to assess the effects of higher dose corticosteroids
in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive
mechanical ventilation, or extracorporeal membrane oxygenation.